A Randomized, Placebo-Controlled, Blind-Start, Single-Cr

Project: Research project

Project Details

Description

A Randomized, Placebo-Controlled, Blind-Start, Single-Crossover Phase 3 Study to Assess the Efficacy and Safety of UX003 rhGUS Enzyme Replacement Therapy in Patients with MPS 7
StatusFinished
Effective start/end date6/1/1711/1/17

Funding

  • Ultragenyx Pharmaceutical Inc

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.